News | Vetter Pharma

Vetter continues its long-term investment strategy to sustain future growth

21.10.2020

Existing buildings are repurposed as others continue to be built and recently housed.

Teaming up to tackle drug development complexity

07.10.2020

Vetter and Rentschler Biopharma are collaboratively developing a best-in-breed approach that reduces time-to-market.

Increasing regulatory requirements demand innovative production methods

06.10.2020

Ute Schleyer spoke with Outsourcing-Pharma about the factors driving demand for aseptic solutions, including V-CRT®.

Vetter opens new Training Center

15.09.2020

In September 2020, Vetter trainees started learning and working in the new Vetter training center

Vetter achieves carbon dioxide-neutral levels

29.07.2020

Success for Vetter Laboratories

22.07.2020

The Swiss University of St. Gallen has certified that the Vetter QC Laboratories are of above-average quality.

Vetter expands its Development Service with new site in Austria

08.07.2020

Joint goals: Rentschler Biopharma and Vetter

06.07.2020

Vetter and Rentschler Biopharma team up to simplify processes and optimize time-to-market.

5 key factors in successful secondary packaging strategy

19.06.2020

Five key considerations we share with companies who are deciding where and when to make key decisions about their secondary packaging strategy.

Vetter wins Axia Best Managed Company Award

28.05.2020

A jury of experts are convinced: Vetter is a symbol for the future of Germany as a business location!